Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 14.83% vs 15.45% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -39.68% vs 25.88% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -18.37% vs -9.36% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -23.57% vs 36.60% in Mar 2024
Compare Profit and Loss Results of Star Health Insu
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
15,594.00
15.00
15,579.00
103,860.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
15,594.00
15.00
15,579.00
103,860.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1,692.00
5.00
1,687.00
33,740.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
0.00
-1.00
1.00
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
-62.00
0.00
-62.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
15,049.00
23.00
15,026.00
65,330.43%
Operating Profit (PBDIT) excl Other Income
544.00
-8.00
552.00
6,900.00%
Other Income
518.00
0.00
518.00
0%
Operating Profit (PBDIT)
1,063.00
-7.00
1,070.00
15,285.71%
Interest
130.00
0.00
130.00
0%
Profit before Depriciation and Tax
933.00
-7.00
940.00
13,428.57%
Depreciation
71.00
1.00
70.00
7,000.00%
Profit Before Taxation & Exceptional Items
861.00
-8.00
869.00
10,862.50%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
861.00
-8.00
869.00
10,862.50%
Provision for Tax
215.00
0.00
215.00
0%
Profit After Tax
645.00
-9.00
654.00
7,266.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-286.00
1,838.00
-2,124.00
-115.56%
Profit Available for appropriations
359.00
1,829.00
-1,470.00
-80.37%
Appropriations
359.00
1,829.00
-1,470.00
-80.37%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
11.01
-0.27
11.28
4,177.78%
Profit And Loss - Net Sales
Net Sales 15,594.02 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.83% vs 15.45% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 544.89 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -39.68% vs 25.88% in Mar 2024
Profit And Loss - Interest
Interest 130.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.37% vs -9.36% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 645.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -23.57% vs 36.60% in Mar 2024






